652 related articles for article (PubMed ID: 23200680)
1. GPU-accelerated nonparametric kinetic analysis of DCE-MRI data from glioblastoma patients treated with bevacizumab.
Hsu YH; Ferl GZ; Ng CM
Magn Reson Imaging; 2013 May; 31(4):618-23. PubMed ID: 23200680
[TBL] [Abstract][Full Text] [Related]
2. An automated method for nonparametric kinetic analysis of clinical DCE-MRI data: application to glioblastoma treated with bevacizumab.
Ferl GZ; Xu L; Friesenhahn M; Bernstein LJ; Barboriak DP; Port RE
Magn Reson Med; 2010 May; 63(5):1366-75. PubMed ID: 20432307
[TBL] [Abstract][Full Text] [Related]
3. Noncompartmental kinetic analysis of DCE-MRI data from malignant tumors: Application to glioblastoma treated with bevacizumab.
Port RE; Bernstein LJ; Barboriak DP; Xu L; Roberts TP; van Bruggen N
Magn Reson Med; 2010 Aug; 64(2):408-17. PubMed ID: 20665785
[TBL] [Abstract][Full Text] [Related]
4. Dynamic contrast-enhanced magnetic resonance imaging of tumors: preclinical validation of parametric images.
Egeland TA; Simonsen TG; Gaustad JV; Gulliksrud K; Ellingsen C; Rofstad EK
Radiat Res; 2009 Sep; 172(3):339-47. PubMed ID: 19708783
[TBL] [Abstract][Full Text] [Related]
5. Subcompartmentalization of extracellular extravascular space (EES) into permeability and leaky space with local arterial input function (AIF) results in improved discrimination between high- and low-grade glioma using dynamic contrast-enhanced (DCE) MRI.
Sahoo P; Rathore RK; Awasthi R; Roy B; Verma S; Rathore D; Behari S; Husain M; Husain N; Pandey CM; Mohakud S; Gupta RK
J Magn Reson Imaging; 2013 Sep; 38(3):677-88. PubMed ID: 23390002
[TBL] [Abstract][Full Text] [Related]
6. Reproducibility of the aortic input function (AIF) derived from dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) of the kidneys in a volunteer study.
Mendichovszky IA; Cutajar M; Gordon I
Eur J Radiol; 2009 Sep; 71(3):576-81. PubMed ID: 19004588
[TBL] [Abstract][Full Text] [Related]
7. Reproducibility of perfusion parameters in dynamic contrast-enhanced MRI of lung and liver tumors: effect on estimates of patient sample size in clinical trials and on individual patient responses.
Ng CS; Raunig DL; Jackson EF; Ashton EA; Kelcz F; Kim KB; Kurzrock R; McShane TM
AJR Am J Roentgenol; 2010 Feb; 194(2):W134-40. PubMed ID: 20093564
[TBL] [Abstract][Full Text] [Related]
8. MRI assessment of relapsed glioblastoma during treatment with bevacizumab: volumetric measurement of enhanced and FLAIR lesions for evaluation of response and progression--a pilot study.
Pichler J; Pachinger C; Pelz M; Kleiser R
Eur J Radiol; 2013 May; 82(5):e240-5. PubMed ID: 23399039
[TBL] [Abstract][Full Text] [Related]
9. Dynamic contrast-enhanced MRI in head-and-neck cancer: the impact of region of interest selection on the intra- and interpatient variability of pharmacokinetic parameters.
Craciunescu OI; Yoo DS; Cleland E; Muradyan N; Carroll MD; MacFall JR; Barboriak DP; Brizel DM
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):e345-50. PubMed ID: 21985945
[TBL] [Abstract][Full Text] [Related]
10. GPU-accelerated compartmental modeling analysis of DCE-MRI data from glioblastoma patients treated with bevacizumab.
Hsu YH; Huang Z; Ferl GZ; Ng CM
PLoS One; 2015; 10(3):e0118421. PubMed ID: 25786263
[TBL] [Abstract][Full Text] [Related]
11. Comparison of tumor histology to dynamic contrast enhanced magnetic resonance imaging-based physiological estimates.
Aref M; Chaudhari AR; Bailey KL; Aref S; Wiener EC
Magn Reson Imaging; 2008 Nov; 26(9):1279-93. PubMed ID: 18487033
[TBL] [Abstract][Full Text] [Related]
12. Comparison of analytical and numerical analysis of the reference region model for DCE-MRI.
Lee J; Cárdenas-Rodríguez J; Pagel MD; Platt S; Kent M; Zhao Q
Magn Reson Imaging; 2014 Sep; 32(7):845-53. PubMed ID: 24925838
[TBL] [Abstract][Full Text] [Related]
13. An adaptive model for rapid and direct estimation of extravascular extracellular space in dynamic contrast enhanced MRI studies.
Dehkordi AN; Kamali-Asl A; Ewing JR; Wen N; Chetty IJ; Bagher-Ebadian H
NMR Biomed; 2017 May; 30(5):. PubMed ID: 28195664
[TBL] [Abstract][Full Text] [Related]
14. Dynamic contrast-enhanced micro-computed tomography correlates with 3-dimensional fluorescence ultramicroscopy in antiangiogenic therapy of breast cancer xenografts.
Pöschinger T; Renner A; Eisa F; Dobosz M; Strobel S; Weber TG; Brauweiler R; Kalender WA; Scheuer W
Invest Radiol; 2014 Jul; 49(7):445-56. PubMed ID: 24598441
[TBL] [Abstract][Full Text] [Related]
15. Assessment of vessel permeability by combining dynamic contrast-enhanced and arterial spin labeling MRI.
Liu HL; Chang TT; Yan FX; Li CH; Lin YS; Wong AM
NMR Biomed; 2015 Jun; 28(6):642-9. PubMed ID: 25880892
[TBL] [Abstract][Full Text] [Related]
16. The application of dynamic contrast-enhanced MRI and diffusion-weighted MRI in patients with maxillofacial tumors.
Kitamoto E; Chikui T; Kawano S; Ohga M; Kobayashi K; Matsuo Y; Yoshiura T; Obara M; Honda H; Yoshiura K
Acad Radiol; 2015 Feb; 22(2):210-6. PubMed ID: 25442795
[TBL] [Abstract][Full Text] [Related]
17. Computer-aided diagnosis of breast DCE-MRI using pharmacokinetic model and 3-D morphology analysis.
Wang TC; Huang YH; Huang CS; Chen JH; Huang GY; Chang YC; Chang RF
Magn Reson Imaging; 2014 Apr; 32(3):197-205. PubMed ID: 24439361
[TBL] [Abstract][Full Text] [Related]
18. A comparison of two methods for estimating DCE-MRI parameters via individual and cohort based AIFs in prostate cancer: a step towards practical implementation.
Fedorov A; Fluckiger J; Ayers GD; Li X; Gupta SN; Tempany C; Mulkern R; Yankeelov TE; Fennessy FM
Magn Reson Imaging; 2014 May; 32(4):321-9. PubMed ID: 24560287
[TBL] [Abstract][Full Text] [Related]
19. Optimizing MRI scan time in the computation of pharmacokinetic parameters (K(trans) ) in breast cancer diagnosis.
Jena A; Mehta SB; Taneja S
J Magn Reson Imaging; 2013 Sep; 38(3):573-9. PubMed ID: 23349046
[TBL] [Abstract][Full Text] [Related]
20. Quantitative analysis of dynamic contrast enhanced MRI for assessment of bowel inflammation in Crohn's disease pilot study.
Oto A; Fan X; Mustafi D; Jansen SA; Karczmar GS; Rubin DT; Kayhan A
Acad Radiol; 2009 Oct; 16(10):1223-30. PubMed ID: 19524458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
